Clinical Effects of Nutrition on Metabolic Risk Factors and Mechanisms
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
The overall aim for this study is to evaluate the clinical effects of a modified diet on metabolic risk factors such as diabetes mellitus and obesity, and the mechanisms this nutrition composition exerts on gastrointestinal physiology, inflammatory responses, and quality of life, where the subjects are their own controls. Within this study, the investigators will be able to relate the nutritional composition to metabolic disorders, the gut microbiota, secreted intestinal neuropeptides, and bio- and inflammatory markers in serum, plasma and urine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Nov 2014
Typical duration for not_applicable obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 23, 2015
CompletedFirst Posted
Study publicly available on registry
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedJanuary 10, 2018
January 1, 2018
12 months
February 23, 2015
January 9, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in metabolic effects, intestinal permeability and microbiota composition after food intervention
In the larger study, the investigator will give the patients a moderate, low carbohydrate food for 3 months and then evaluate the effects in plasma concentration of insulin, fp-glucose, C-peptide, proinsulin, HbA1c, lipids, and zonulin. Feces wil be analyzed for microbiota composition as quantified by PCR.
3 months
Secondary Outcomes (1)
Quality of life as assessed by the SF-36
3 months
Other Outcomes (1)
Change from baseline in hormonal effects of food intervention
3 hours
Study Arms (2)
low carbohydrate food
EXPERIMENTALThe subjects will be given a diet with moderate, low carbohydrate content for 3 months, or as a single test meal, and this will be evaluated in metabolic parameters, microbiota and biomarkers in serum as described previously. Intervention: Food: Low carbohydrate food
standard food
ACTIVE COMPARATORThe subjects will be given a diet with standard food as a single test meal, and this will be evaluated in metabolic parameters, microbiota and biomarkers in serum, as described Intervention: Food: Standard food
Interventions
Eligibility Criteria
You may qualify if:
- Healthy subjects should be healthy.
- Prediabetes should have fasting plasma glucose levels o 5.6-6.9 mmol/l or plasma glucose level 2 h after an oral glucose test of 7.8-11.1 mmol/l, without any diabetes treatment.
- Patients with diabetes should have type-2 diabetes.
- Obesity should have BMI 30-3 and glucose levels within reference values
You may not qualify if:
- Patients with diabetes or obesity should not have severe cardiac, kidney, liver or psychiatric diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
- Lund Universitycollaborator
Related Publications (2)
Ohlsson B, Bjorgell O, Ekberg O, Darwiche G. The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. BMC Gastroenterol. 2006 Mar 16;6:11. doi: 10.1186/1471-230X-6-11.
PMID: 16542457BACKGROUNDSullivan M, Karlsson J, Taft C. SF-36: Swedish manual and interpretation guide, 2nd Edition. Gothenburg: Sahlgrenska University Hospital. 2002.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bodil Ohlsson, Professor
Lund University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, senior consultant
Study Record Dates
First Submitted
February 23, 2015
First Posted
April 1, 2015
Study Start
November 1, 2014
Primary Completion
October 15, 2015
Study Completion
December 31, 2017
Last Updated
January 10, 2018
Record last verified: 2018-01